Sponsored

Transforming Early Symptomatic Alzheimer’s Disease Diagnostics: The Emerging Role and Potential Impact of Blood Biomarker Testing in Early Detection

September 2nd 2025

Recognizing Friedreich Ataxia: Diagnosis and Management

BySusan A. Perlman, M.D., Clinical Professor of Neurology and Director, Ataxia Center and HD Center of Excellence at the David Geffen School of Medicine at UCLA

August 20th 2025

Confronting Alzheimer’s Disease: The Changing Biomarker and Treatment Landscape

April 7th 2025

Dr. Theodore H. Schwartz: Removing Skull Base Tumors through the Lateral Transorbital Approach (LTOA)

ByNewYork_Presbyterian

October 15th 2024

Exploring a Holistic Approach to Rare Disease: Finding Flexibility and Convenience in a CIDP Treatment

BySponsored by CSL Behring

May 28th 2024

Charting New Territories in Early Alzheimer’s Disease: Insights Into A Treating Physician’s Experience with LEQEMBI® (lecanemab-irmb)

BySponsored by Eisai Inc. and Biogen

April 12th 2024

The Future of Parkinson’s Disease: Symptom Management and Beyond

April 5th 2024

Clinical Trial Design in Alzheimer’s Disease Research

March 27th 2024

How Early Intervention and a Treatment Can Help Early Alzheimer’s Disease

March 7th 2024

High-Efficacy Disease-Modifying Therapies for Multiple Sclerosis

ByJason Freeman, MD, MBA,Abby Rogers, DMSc, PA-C, MPAS

December 18th 2023

Jason Freeman, MD, MBA, and Abby Rogers, DMSc, PA-C, MPAS, discuss a study presented at ACTRIMS 2023 on high-efficacy disease-modifying therapies for treatment-naïve patients with multiple sclerosis. Sponsored by Novartis.

The Role of Serum Biomarkers in the Management of MS

ByJason Freeman, MD, MBA,Gina Mavrikis Cox, PhD

December 18th 2023

Jason Freeman, MD, MBA, and Gina Mavrikis Cox, PhD, discuss a presentation from CMSC 2023 on the role of serum biomarkers in multiple sclerosis management. Sponsored by Novartis.

Understanding Physical and Cognitive Functioning in Patients With Relapsing Multiple Sclerosis

October 2nd 2023

Call to Action: Teva Dedicated to Improving Lives of Patients Suffering from Tardive Dyskinesia (TD)

September 25th 2023

Together is Better: Pushing Boundaries in Brain Health

September 7th 2023

Maximizing "On" Time: Longer-Lasting Levodopa Therapy Options for Parkinson's Disease

ByKhashayar Dashtipour, M.D., Ph.D.

May 24th 2023

The Last Frontier of Medicine

ByRaymond Sanchez, MD

April 21st 2023

The Importance of Two-Way Communication in the Management of hATTR Amyloidosis

February 15th 2023

Case Study and Overview of WAKIX® (pitolisant) Tablets in the Treatment of Excessive Daytime Sleepiness and/or Cataplexy in Adults with Narcolepsy

ByMichael J. Thorpy, MD

January 31st 2023

An Oral CGRP-Targeted Treatment Option for Migraine Prevention

October 12th 2022

Applying two decades of Alzheimer’s research and doing what’s right for patients

ByGregory A. Rippon, MD, MS

September 22nd 2022

Disability Insurance: Overview, What to Look For, Mistakes to Avoid

March 24th 2022

Advance in Remote Care Benefits Movement Disorder Patients

ByBinith Cheeran, MD, PhD

February 14th 2022

Patient Perspectives on Living with an Ultra-Rare Mitochondrial Disease: Thymidine Kinase 2 Deficiency (TK2d)

January 28th 2022

A Proven Option for Reversing Morning Akinesia for Patients With Parkinson Disease

January 13th 2022

The results of a phase 4 study demonstrate the efficacy of APOKYN® (apomorphine hydrochloride injection) treatment.

The Duchenne Muscular Dystrophy (DMD) Continuum: The Case for Early Intervention and Long-term Treatment

December 13th 2021

Breakthroughs in NMOSD: Better Understanding the Science and Treatment

November 9th 2021

How Well Do You Know COPAXONE® (glatiramer acetate injection)?

October 22nd 2021

This year, Teva is celebrating the 25th anniversary of the FDA approval of COPAXONE® (glatiramer acetate injection), but the story goes back much further. Hear what some of Teva's most prominent R&D leaders have to say about the history and origins of the treatment.

Helping Patients Identify and Manage Parkinson’s Disease OFF Episodes

ByRamon L. Rodriguez, MD

September 7th 2021